Drug Detail

Information about Binimetinib + Pexidartinib

Generic Name	Binimetinib + Pexidartinib
IND
Brand Name (US)
Manufacturer
Drug Type	Tyrosine Kinase Inhibitor
Delivery	Oral
Approval Status
Indications
Overall Strategy	KIT Protein Based + Oncogenic Signal Path Based
Strategy
Drug Category	KIT/PDGFRA inhibitor + MEK inhibitor

Links
Trials of this drug
	A Study of MEK162 (Binimetinib) in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

Trial results